Boston Therapeutics, Inc. (5)

Browse by Contract Category

Contracts

Certificate of Designation Series B Preferred Stock (Filed With SEC on February 2, 2021)
Agreement and Plan of Merger, dated February 2, 2021, by and between Boston Therapeutics, Inc.., BTHE Acquisition Inc. and Nanomix, Inc (Filed With SEC on February 2, 2021)
Form of Debt Settlement and Release Agreement (Filed With SEC on February 2, 2021)
Unwind Agreement between Boston Therapeutics, Inc., Cure DM, Inc. and Cure DM Group Holdings, LLC signed August 6, 2019 (Filed With SEC on August 19, 2019)
Form of Exchange Agreement (Filed With SEC on February 2, 2021)